HOUSTON, Sept. 20,
2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex
Health" or the "Company") (NASDAQ: NUTX), a physician-led,
technology-enabled integrated healthcare delivery system comprised
of 22 state-of-the-art micro hospitals in 8 states and primary
care-centric, risk-bearing physician networks, today announced that
Thomas Vo, M.D., MBA, Founder,
Chairman and CEO will be participating in the 2023 Cantor
Fitzgerald Global Healthcare Conference from Tuesday, September 26 to Thursday, September 28 in New York City.
Nutex Health Presentation Details:
Date: Thursday, September 28,
2023
Time: 12:05pm – 12:35pm ET
Location: Track 5
Venue: InterContinental New York Barclay Hotel
In addition to the formal presentation, Dr. Vo will be available
to participate in one-on-one meetings with qualified members of the
investor community who are registered to attend the conference.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011,
Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and
operations company with two divisions: a Hospital Division and a
Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 22 facilities in 8 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). Through our Management Services Organization (MSO), we
provide management, administrative and other support services to
our affiliated hospitals and physician groups. Our cloud-based
proprietary technology platform aggregates clinical and claims data
across multiple settings, information systems and sources to create
a holistic view of patients and providers, allowing us to deliver
greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "will continue," "anticipated," "estimate,"
"projected," "intend," "goal," or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks, known and unknown, and uncertainties,
many of which are beyond the control of the Company. Such
uncertainties and risks include, but are not limited to, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including the interim final and final rules
implemented under the No Surprises Act , economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in the Current Report on Form 10-Q for the
period ended March 31, 2023 under the heading "Risk
Factors" in Part I, Item IA thereof, and other documents filed from
time to time with the Securities and Exchange Commission. Such
factors could materially adversely affect the Company's financial
performance and could cause the Company's actual results for future
periods to differ materially from any opinions or statements
expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-announces-participation-in-the-2023-cantor-fitzgerald-global-healthcare-conference-301932903.html
SOURCE Nutex Health, Inc.